Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 ,inter alia, to consider and approve To consider the appointment of Mr. Chintan Didawala Ganpat (DIN: 11088268) as ManagingDirector of the Company.2. To consider the Alteration in Main Objects Clause of Memorandum of Association of the Company by addition of New Objects.3. To consider the Increase in the Authorized Share Capital of the Company and consequent amendment in Memorandum of the Company, if any;4. Conduct Postal Ballot by means of E-voting for obtaining approval of the members of the Company
Welcure Drugs And Pharmaceuticals Ltd. Press Release May 09 2025
Filed with BSE · · 2 pages · English
Release
Welcure Drugs and Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Welcure Drugs and Pharmaceuticals
- Welcure Drugs And Pharmaceuticals Ltd. Press Release May 06 2025
- Announcement under Regulation 30 (LODR)-Change in Management
- Appointment of Company Secretary and Compliance Officer
- Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs &Pharmaceuticals Ltd Held On Today I.E. Tuesday, 06Th May, 2025.
- Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Later from Welcure Drugs and Pharmaceuticals
- Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Limited
- Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
- Welcure Drugs And Pharmaceuticals Ltd. Press Release May 14 2025
- Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
- Welcure Drugs And Pharmaceuticals Ltd. Press Release May 15 2025
Follow Welcure Drugs and Pharmaceuticals into a list and get an email when it puts out news.
Follow Welcure Drugs and Pharmaceuticals